نتایج جستجو برای: pcr tas

تعداد نتایج: 178070  

Journal: :In vivo 2009
Roberta M Johnke Judy M Edwards Mark J Evans Gladys N Nangami Nicholas T G Bakken Jeremy M Kilburn Tung-Kwang Lee Ron R Allison Ulf L Karlsson Hyder H Arastu

BACKGROUND The purpose of this study was to investigate the immunological impact of combining neoadjuvant total androgen suppression (TAS) with radiotherapy (xRT) in the treatment of prostate cancer by monitoring blood cytokine levels. PATIENTS AND METHODS Participants were stage I-II prostate cancer patients receiving xRT alone (n=18) or TAS+xRT (n=19) under the procedures outlined in RTOG p...

2013
Anne Tsao Edwin Pun Hui Rosalyn Juergens Shanthi Marur Tan Eng Huat Goh Boon Cher Ruey-Long Hong Waun Ki Hong Anthony Tak-Cheung Chan

TAS-106, a RNA polymerase inhibitor, was studied in solid tumors with potential clinical benefit and reasonable tolerability. We conducted a multicenter, international phase II trial of TAS-106 in salvage metastatic or recurrent head and neck squamous cell cancer (HNSCC) and nasopharyngeal cancer (NPC) patients. TAS-106 monotherapy was given at 6.5 mg/m(2) over 24-h continuous infusion every 3 ...

Journal: :Biopsychosocial Medicine 2007
Yoshiya Moriguchi Motonari Maeda Tetsuya Igarashi Toshio Ishikawa Masayasu Shoji Chiharu Kubo Gen Komaki

BACKGROUND The construct validity of alexithymia and its assessment using the 20-item Toronto Alexithymia Scale (TAS-20) in Japan is unknown. Low reliability has been found for the third factor of the TAS-20 in some cultures, and the factor structure for psychosomatic disorder patients has not been adequately investigated. Although alexithymia most likely has certain developmental aspects, this...

2011
Fatemeh Bazvand Sedigheh Shams Mahtab Borji Esfahani Lili Koochakzadeh Maryam Monajemzadeh Mohammad-Taghi Haghi Ashtiani Nima Rezaei

OBJECTIVE Beta-thalassemia major is an autosomal recessive disease causing severe and hemolytic anemia, which begins about 2-6 months after birth. Iron overload, which arises from recurrent transfusion and ineffective erythropoiesis, can enhance oxidative stress in thalassemic patients. The aim of this study was to evaluate the serum total antioxidant capacity of patients with ß-Thalassemia maj...

Journal: :Anticancer research 2015
Mamoru Nukatsuka Fumio Nakagawa Hitoshi Saito Minoru Sakata Junji Uchida Teiji Takechi

TAS-102 is a novel oral nucleoside antitumor agent consisting of trifluridine and tipiracil hydrochloride at a molar ratio of 1:0.5. TAS-102 was approved in Japan in March 2014 for the treatment of patients with unresectable, advanced or recurrent colorectal cancer that is refractory to standard therapies. In the present study, enhancement of the therapeutic efficacy using a combination therapy...

Journal: :Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme 2007
Cecilia M Shing Jonathan M Peake Shannon M Ahern Natalie A Strobel Gary Wilson David G Jenkins Jeff S Coombes

We examined the influence of 3 consecutive days of high-intensity cycling on blood and urinary markers of oxidative stress. Eight highly-trained male cyclists (VO2 max 76 +/- 4 mL.kg-1.min-1; mean +/- SD) completed an interval session (9 exercise bouts lasting 30 s each, at 150% peak power output) on day 1, followed by 2 laboratory-simulated 30 km time trials on days 2 and 3. The cyclists also ...

2014
NOZOMU TANAKA KAZUKI SAKAMOTO HIROYUKI OKABE AKIO FUJIOKA KEISUKE YAMAMURA FUMIO NAKAGAWA HIDEKI NAGASE TATSUSHI YOKOGAWA KEI OGUCHI KEIJI ISHIDA AKIKO OSADA HIROMI KAZUNO YUKARI YAMADA KENICHI MATSUO

TAS-102 is a novel oral nucleoside antitumor agent containing trifluridine (FTD) and tipiracil hydrochloride (TPI). The compound improves overall survival of colorectal cancer (CRC) patients who are insensitive to standard chemotherapies. FTD possesses direct antitumor activity since it inhibits thymidylate synthase (TS) and is itself incorporated into DNA. However, the precise mechanisms under...

Journal: :Atherosclerosis 2013
Christina Lundberg Lars Johansson Charlotte Ebeling Barbier Lars Lind Håkan Ahlström Tomas Hansen

OBJECTIVE The purpose of the present study was to investigate the relationship between the Total Atherosclerotic Score (TAS), a measurement of the overall atherosclerotic burden of the arterial tree by whole body magnetic resonance angiography (WBMRA), and the risk of major adverse cardiovascular events (MACE), defined as cardiac death, myocardial infarction, stroke and/or coronary revasculariz...

2013
Erwin Lemche Michael J. Brammer Anthony S. David Simon A. Surguladze Mary L. Phillips Mauricio Sierra Steven C.R. Williams Vincent P. Giampietro

It is unclear to what degree depersonalization disorder (DPD) and alexithymia share abnormal brain mechanisms of emotional dysregulation. We compared cerebral processing of facial expressions of emotion in individuals with DPD to normal controls (NC). We presented happy and sad emotion expressions in increasing intensities from neutral (0%) through mild (50%) to intense (100%) to DPD and non-re...

2013
Brian K. Chu Michael Deming Nana-Kwadwo Biritwum Windtaré R. Bougma Améyo M. Dorkenoo Maged El-Setouhy Peter U. Fischer Katherine Gass Manuel Gonzalez de Peña Leda Mercado-Hernandez Dominique Kyelem Patrick J. Lammie Rebecca M. Flueckiger Upendo J. Mwingira Rahmah Noordin Irene Offei Owusu Eric A. Ottesen Alexandre Pavluck Nils Pilotte Ramakrishna U. Rao Dilhani Samarasekera Mark A. Schmaedick Sunil Settinayake Paul E. Simonsen Taniawati Supali Fasihah Taleo Melissa Torres Gary J. Weil Kimberly Y. Won

BACKGROUND Lymphatic filariasis (LF) is targeted for global elimination through treatment of entire at-risk populations with repeated annual mass drug administration (MDA). Essential for program success is defining and confirming the appropriate endpoint for MDA when transmission is presumed to have reached a level low enough that it cannot be sustained even in the absence of drug intervention....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید